• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Side effects analyses in consideration of renal function for S-1-administered patients].

作者信息

Iwai Mina, Kimura Michio, Yoshimura Tomoaki, Yasuda Tadashi

机构信息

Dept. of Pharmacy, Ogaki Municipal Hospital.

出版信息

Gan To Kagaku Ryoho. 2011 Jun;38(6):973-6.

PMID:21677489
Abstract

Although many analyses of S-1 side effects are reported, there are no reports where the analyses of side effects were performed in consideration of renal function, which is an important index of medication dose. Therefore, we investigated side effects in consideration of renal function. The subjects were 163 patients administered S-1 at the Department of Surgery of Ogaki Municipal Hospital, between October 2008 and December 2009. The frequency and severity of side effects were high and serious in the groupwhose creatinine clearance was low. A significant difference was observed among 3 groups with regard to thrombocytopenia and dehydration. In conclusion, we think that pharmacists must take renal function into consideration when administering medication, to keepclose medicinal guidance, and to actively observe progress.

摘要

相似文献

1
[Side effects analyses in consideration of renal function for S-1-administered patients].
Gan To Kagaku Ryoho. 2011 Jun;38(6):973-6.
2
[The Importance of Medication History Management by Hospital and Community Pharmacists for Oral Anticancer Drug S-1(Tegafur/Gimeracil/Oteracil Potassium)--A Retrospective Study].
Gan To Kagaku Ryoho. 2016 Jan;43(1):79-83.
3
[Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].[晚期胃癌患者辅助化疗的S-1疗法研究]
Gan To Kagaku Ryoho. 2009 Jun;36(6):953-7.
4
[S-1-based chemotherapy for unresectable advanced gastric cancer of the elderly or patients with renal dysfunction].[基于S-1的老年不可切除晚期胃癌或肾功能不全患者的化疗]
Gan To Kagaku Ryoho. 2011 Nov;38(11):1817-20.
5
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study.S-1 一线治疗 75 岁以上晚期胃癌老年患者的 II 期研究:东京协同肿瘤学组研究。
Cancer Chemother Pharmacol. 2010 May;65(6):1093-9. doi: 10.1007/s00280-009-1114-6. Epub 2009 Aug 30.
6
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.S-1单药治疗对紫杉醇和顺铂耐药的胃癌的II期研究。
Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29.
7
An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.S-1 治疗日本细胞因子难治性转移性肾细胞癌患者的早期 II 期试验。
Cancer Chemother Pharmacol. 2010 Nov;66(6):1065-70. doi: 10.1007/s00280-010-1262-8. Epub 2010 Feb 16.
8
Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.口服氟嘧啶S-1用于晚期胃癌短期和长期给药的安全性评估:3758例患者的分析
Cancer Chemother Pharmacol. 2008 Feb;61(2):335-43. doi: 10.1007/s00280-007-0595-4. Epub 2007 Oct 9.
9
High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.新型口服氟嘧啶S-1治疗胰腺癌患者的缓解率较高。
Oncol Rep. 2002 Nov-Dec;9(6):1355-61.
10
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.使用口服氟嘧啶S-1对胃癌进行辅助化疗。
N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252.